Search research articles
Contact Us
Filters
Showing results (171-180 of 178) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 178 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group
M Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical Breast Cancer
|
April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
E Van Cutsem, C Twelves, J Cassidy, et al.
The New England Journal of Medicine
|
October 7, 1982
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma
U Veronesi, J Adamus, C Aubert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E Bajetta, I Floriani, M Di Bartolomeo, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
ESMO Open
|
June 5, 2025
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)
M J Naughton, D M Zahrieh, M Gnant, et al.
ESMO Open
|
November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)
F Spada, F Gelsomino, M Rinzivillo, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 178) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 178 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2000
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group
M Kaufmann, E Bajetta, L Y Dirix, et al.
Clinical Breast Cancer
|
April 24, 2002
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
E Van Cutsem, C Twelves, J Cassidy, et al.
The New England Journal of Medicine
|
October 7, 1982
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma
U Veronesi, J Adamus, C Aubert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
E Bajetta, I Floriani, M Di Bartolomeo, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
ESMO Open
|
June 5, 2025
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)
M J Naughton, D M Zahrieh, M Gnant, et al.
ESMO Open
|
November 12, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)
F Spada, F Gelsomino, M Rinzivillo, et al.
Page
of 18